Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Langa

Showing results (1-10 of 391) with videos related to

Pageof 40
Sort By:
Alzheimer'S Research & Therapy|March 28, 2015
Is the risk of Alzheimer's disease and dementia declining?Kenneth M Langa
The American Journal of Managed Care|May 22, 2004
An illness in the family: accounting for the complex effects of illness on other family membersKenneth M Langa
Big Data|October 22, 2015
Opportunities for New Insights on the Life-Course Risks and Outcomes of Cognitive Decline in the Kavli HUMAN ProjectKenneth M Langa, David Cutler
Alzheimer Disease and Associated Disorders|December 31, 2010
Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS)Toru Okura, Kenneth M Langa
JAMA Internal Medicine|October 18, 2016
Unfinished Business in Preventing Alzheimer DiseaseJason Karlawish, Kenneth M Langa
JAMA|December 17, 2014
The diagnosis and management of mild cognitive impairment: a clinical reviewKenneth M Langa, Deborah A Levine
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 11, 2011
Vascular cognitive impairment: disease mechanisms and therapeutic implicationsDeborah A Levine, Kenneth M Langa
JAMA Internal Medicine|December 3, 2019
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-ReplyJames F Burke, Kenneth M Langa
JAMA Internal Medicine|July 9, 2019
Preclinical Alzheimer Disease-Early Diagnosis or Overdiagnosis?Kenneth M Langa, James F Burke
Critical Reviews in Oncology/Hematology|June 7, 2003
Estimating the costs of caring for the older breast cancer patientJames A Hayman, Kenneth M Langa
Pageof 40

Showing results (1-10 of 391) with videos related to

Sort By:
Pageof 40
Alzheimer'S Research & Therapy|March 28, 2015
Is the risk of Alzheimer's disease and dementia declining?Kenneth M Langa
The American Journal of Managed Care|May 22, 2004
An illness in the family: accounting for the complex effects of illness on other family membersKenneth M Langa
Big Data|October 22, 2015
Opportunities for New Insights on the Life-Course Risks and Outcomes of Cognitive Decline in the Kavli HUMAN ProjectKenneth M Langa, David Cutler
Alzheimer Disease and Associated Disorders|December 31, 2010
Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS)Toru Okura, Kenneth M Langa
JAMA Internal Medicine|October 18, 2016
Unfinished Business in Preventing Alzheimer DiseaseJason Karlawish, Kenneth M Langa
JAMA|December 17, 2014
The diagnosis and management of mild cognitive impairment: a clinical reviewKenneth M Langa, Deborah A Levine
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 11, 2011
Vascular cognitive impairment: disease mechanisms and therapeutic implicationsDeborah A Levine, Kenneth M Langa
JAMA Internal Medicine|December 3, 2019
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-ReplyJames F Burke, Kenneth M Langa
JAMA Internal Medicine|July 9, 2019
Preclinical Alzheimer Disease-Early Diagnosis or Overdiagnosis?Kenneth M Langa, James F Burke
Critical Reviews in Oncology/Hematology|June 7, 2003
Estimating the costs of caring for the older breast cancer patientJames A Hayman, Kenneth M Langa
Pageof 40